Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases, Published online: 27 March 2024; doi:10.1038/s41391-024-00816-0Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer

Source: Prostate Cancer and Prostatic Diseases - March 27, 2024 Category: Urology & Nephrology Authors: Daniel J. George Krishnan Ramaswamy Hongbo Yang Qing Liu Adina Zhang Alexandra Greatsinger Jasmina Ivanova Betty Thompson Birol Emir Agnes Hong Stephen J. Freedland Source Type: research